Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227

4 Pogledi
administrator
administrator
07/30/23

For more information, visit https://ascopubs.org/doi/full/10.1200/JCO.22.01503

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći